January 19, 2024 | Hybrid activity out of Charlotte, NC
Activity Overview
No field in medicine has a faster pace of change, innovation and randomized trial data than cardiovascular disease. An annual update of the broad range of cardiovascular issues for physicians, advanced practice providers and nurses is always of great intrinsic value. It is increasingly difficult for cardiologists to stay current with the various aspects of CV disease, diagnosis and treatment. Therefore, other health care providers will always have gaps in their CV knowledge base; our course can be of value to close those gaps.
Target Audience
This activity is designed for an audience of physicians, physician assistants, nurses and nurse practitioners.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Identify evaluation and management strategies for patients with HFpEF.
- Recognize the importance of cardio-oncology programs connecting heart and cancer care.
- Identify evaluation and management strategies for patients with symptomatic venous obstruction.
- Recognize the importance of the diagnosis and contemporary management of patients with cardiac amyloidosis.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claim credit form available here:
Please claim your credit by January 31, 2024.
If you have questions about this CE activity, please contact AKH Inc at [email protected].
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Sanger Heart and Vascular Institute. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses
Credit being awarded: 5.0 ANCC contact hours
Physician Assistant
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioner
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Sanger Heart and Vascular Institute. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 5.0 contact hour(s) (which includes 2.5 hour(s) of pharmacology).
Commercial Support
There is no commercial support for this activity.
| DISCLOSURES | ||
| Name | Relationship | Commercial Interest |
| Tiffany Budroe, NP (faculty) | N/A | Nothing to disclose |
| William Downey, MD (faculty) | N/A | Nothing to disclose |
| Theodore Frank, MD (faculty) | N/A | Nothing to disclose |
| Glen Kowalchuk, MD (faculty) | N/A | Nothing to disclose |
| Rohit Mehta, MD (faculty) | N/A | Nothing to disclose |
| Erin Murphy, MD (faculty) | Consultant | BD/Bard; Boston Scientific; Cordis; Cook; Gore; Medtronic; Philips; Veryn |
| Researcher | Medtronic; Gore; BD/Bard; Mercator | |
| Speaker | BD/Bard; Boston Scientific; Cordis; Cook; Gore; Medtronic; Philips | |
| Amar Parikh, MD (faculty) | N/A | Nothing to disclose |
| Carolyn Park, MD (faculty) | N/A | Nothing to disclose |
| Brian Powell, MD (faculty) | Speaker | Janssen Pharmaceuticals |
| Santosh Rao, MD (faculty) | N/A | Nothing to disclose |
| Jai Singh, MD (faculty) | N/A | Nothing to disclose |
| Gregory Sinner, MD (faculty) | N/A | Nothing to disclose |
| Dorothy Caputo, MA, BSN, RN – VP, Healthcare Continuing Education and Operations | N/A | Nothing to disclose |
| Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer) | N/A | Nothing to disclose |
| Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
| AKH Inc Staff and Planners | N/A | Nothing to disclose |
| Sanger Heart and Vascular Institute Staff and Planners | N/A | Nothing to disclose |
| All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with “Opt Out” in the subject line.
